Takeover

Acquirers

Angelini Pharma S.p.A.

Targets
1
Filings
3
Median premium
36%
First filing
May 7, 2026
Latest filing
Jun 8, 2026

Targets

CompanyScore before dealScore nowFilingsLatest
CATALYST PHARMACEUTICALS, INC.1 / 7—3Jun 8, 2026

Deal filings

FiledCompanyFormPricePremium
Jun 8, 2026CATALYST PHARMACEUTICALS, INC.DEFM14A$31.5035.71%
May 28, 2026CATALYST PHARMACEUTICALS, INC.PREM14A$31.5031.5%
May 7, 2026CATALYST PHARMACEUTICALS, INC.8-K——